Cytokinetics (CYTK)CFO sold ~$307K

~$307K

Approx. value · 4,935 sh @ $62.15

87K

Holds after · shares reported

Traded

Mar 17, 2026

Filed

Mar 18, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Feb 2, 2026InsiderOfficer sold ~$55K of CYTK shares in the open market
2. Feb 5, 2026InsiderOfficer sold ~$929K of CYTK shares in the open market
3. Feb 24, 2026Company filing · Form 8-K · ResultsReported its results
4. Mar 2, 2026Insider · 2 peopleInsiders: 2 sales (~$361K)
5. Mar 5, 2026Insider · 1 personInsiders: 2 sales (~$1.6M)
6. Mar 9, 2026Insider · 3 peopleInsiders: 3 sales (~$815K)
7. Mar 16, 2026InsiderOfficer sold ~$104K of CYTK shares in the open market
8. Mar 17, 2026 · this disclosureInsiderCFO sold ~$307K of CYTK shares in the open market

What came next

1. Mar 17, 2026Insider · 3 peopleInsiders: 6 sales (~$3.6M)
2. Mar 18, 2026InsiderOfficer sold ~$120K of CYTK shares in the open market
3. Mar 31, 2026InsiderOfficer sold ~$237K of CYTK shares in the open market
4. Apr 1, 2026InsiderCEO sold ~$500K of CYTK shares in the open market
5. Apr 7, 2026Insider · 1 personInsiders: 2 sales (~$293K)
6. Apr 15, 2026Insider · 2 peopleInsiders: 2 sales (~$982K)
7. Apr 21, 2026InsiderOfficer sold ~$230K of CYTK shares in the open market
8. Apr 29, 2026InsiderCEO sold ~$447K of CYTK shares in the open market
9. Apr 30, 2026InsiderOfficer sold ~$949K of CYTK shares in the open market
10. May 1, 2026InsiderOfficer sold ~$1.03M of CYTK shares in the open market
11. May 5, 2026Company filing · Form 8-K · ResultsReported its results
12. May 5, 2026Insider · 5 peopleInsiders: 5 sales (~$4.8M)
13. May 14, 2026InsiderCEO sold ~$584K of CYTK shares in the open market
14. May 19, 2026InsiderOfficer sold ~$265K of CYTK shares in the open market
15. May 27, 2026InsiderCEO sold ~$579K of CYTK shares in the open market
16. Jun 1, 2026Insider · 3 peopleInsiders: 3 sales (~$1.7M)
17. Jun 9, 2026InsiderOfficer sold ~$238K of CYTK shares in the open market
18. Jun 15, 2026InsiderCEO sold ~$528K of CYTK shares in the open market
19. Jun 23, 2026InsiderOfficer sold ~$278K of CYTK shares in the open market
20. Jun 24, 2026InsiderCFO sold ~$3.19M of CYTK shares in the open market

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Cytokinetics

For Cytokinetics, OQRO holds 18 insider filings (SEC Form 4 or Form 144) and 11 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CYTK page.

Other recent filings by Sung Lee, EVP, Chief Financial Officer

• SEC Form 4 at Cytokinetics (CYTK)Jul 2, 2026
• SEC Form 4 at Cytokinetics (CYTK)Jun 29, 2026
• SEC Form 4 at Cytokinetics (CYTK)Jun 29, 2026
• SEC Form 4 at Cytokinetics (CYTK)May 5, 2026

The full history of Sung Lee, EVP, Chief Financial Officer is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Cytokinetics

• SEC Form 4Oct 6, 2026
• SEC Form 4Sep 28, 2026
• SEC Form 4Sep 22, 2026
• SEC Form 4Sep 15, 2026
• SEC Form 4Sep 15, 2026
• SEC Form 4Sep 15, 2026

Everything OQRO holds on this company is on its CYTK page.